OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 123 filers reported holding OREXIGEN THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 1.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $10,000 | -99.4% | 17,312 | -98.1% | 0.00% | -100.0% |
| Q4 2015 | $1,569,000 | -18.5% | 911,812 | 0.0% | 0.00% | -33.3% |
| Q3 2015 | $1,924,000 | -27.0% | 911,812 | +71.3% | 0.00% | -25.0% |
| Q2 2015 | $2,634,000 | -30.0% | 532,218 | +10.7% | 0.00% | -33.3% |
| Q1 2015 | $3,764,000 | +28.5% | 480,669 | -0.6% | 0.01% | +20.0% |
| Q4 2014 | $2,929,000 | +32.6% | 483,377 | -6.8% | 0.01% | +25.0% |
| Q3 2014 | $2,209,000 | -28.6% | 518,668 | +3.6% | 0.00% | -20.0% |
| Q2 2014 | $3,095,000 | -6.2% | 500,834 | -1.3% | 0.01% | -16.7% |
| Q1 2014 | $3,299,000 | +20.1% | 507,497 | +4.0% | 0.01% | +20.0% |
| Q4 2013 | $2,747,000 | -6.8% | 487,900 | +1.6% | 0.01% | -16.7% |
| Q3 2013 | $2,947,000 | -1.5% | 480,000 | -6.1% | 0.01% | -14.3% |
| Q2 2013 | $2,992,000 | – | 511,446 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 1,900,000 | $11,106,000 | 1.50% |
| Redmile Group, LLC | 1,190,440 | $6,958,000 | 1.23% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 613,560 | $3,586,000 | 0.63% |
| Montibus Capital Management LLC | 818,575 | $4,784,570,000 | 0.60% |
| KOPP INVESTMENT ADVISORS LLC | 213,752 | $1,249,000 | 0.49% |
| PFM Health Sciences, LP | 3,646,260 | $21,312,000 | 0.44% |
| APEX CAPITAL, LLC | 1,092,900 | $6,388,000 | 0.44% |
| FIRST MANHATTAN CO. LLC. | 6,141,636 | $46,860,000 | 0.32% |
| JHL Capital Group LLC | 300,000 | $1,755,000 | 0.27% |
| Partner Investment Management, L.P. | 188,732 | $1,103,000 | 0.25% |